Infinium Pharmachem Complete Financial Statements
In FYNone, Infinium Pharmachem (INFINIUM) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 7.4% and ROE of 11.6%. Full financial statements from FY2020 to FY2026 (7 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse INFINIUM FII DII holdings to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
INFINIUM Revenue, Net Profit & EBITDA — Year-on-Year Growth
INFINIUM YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. Also explore INFINIUM stock price history to track price trends across different timeframes.
INFINIUM Income Statement — Revenue, EBITDA & Net Profit
Infinium Pharmachem revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 7.4%. For live price, earnings ratios and company overview, see INFINIUM screener.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 190 | 158 | 137 | 116 | 100 | 71 | 39 |
| Expenses | 0 | 168 | 139 | 117 | 98 | 89 | 66 | 36 |
| EBITDA | 0 | 22 | 19 | 20 | 17 | 11 | 6 | 3 |
| Operating Profit Margin % | 0.00% | 11.00% | 11.00% | 14.00% | 14.00% | 10.00% | 7.00% | 6.00% |
| Depreciation | 0 | 3 | 3 | 3 | 1 | 1 | 1 | 1 |
| Interest | 0 | 3 | 4 | 2 | 3 | 2 | 1 | 1 |
| Profit Before Tax | 0 | 18 | 12 | 15 | 13 | 9 | 4 | 1 |
| Tax | 0 | 4 | 4 | 4 | 3 | 2 | 1 | 0 |
| Net Profit | 0 | 14 | 8 | 12 | 10 | 7 | 3 | 1 |
| Earnings Per Share (₹) | 0.00 | 7.80 | 5.60 | 8.12 | 6.82 | 60.07 | 26.80 | 9.19 |
INFINIUM Balance Sheet — Assets, Liabilities & Shareholders' Equity
INFINIUM total assets ₹175 Cr, total equity ₹121 Cr, total liabilities ₹ Cr (2026) — ROE 11.6%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 175 | 198 | 86 | 71 | 59 | 34 | 22 |
| Current Assets | 110 | 140 | 65 | 51 | 44 | 26 | 18 |
| Fixed Assets | 32 | 24 | 20 | 19 | 4 | 5 | 4 |
| Capital Work in Progress | 8 | 1 | 0 | 0 | 9 | 4 | 0 |
| Investments | 39 | 29 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 144 | 66 | 52 | 46 | 26 | 18 |
| LIABILITIES | |||||||
| Total Liabilities | |||||||
| Current Liabilities | 8 | 10 | 8 | 10 | 14 | 6 | 6 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 121 | 125 | 60 | 24 | 14 | 7 | 4 |
| Share Capital | 16 | 16 | 14 | 5 | 1 | 1 | 1 |
| Reserves & Surplus | 106 | 94 | 45 | 18 | 12 | 6 | 3 |
INFINIUM Cash Flow Statement — Operating, Investing & Financing
Infinium Pharmachem operating cash flow ₹-29 Cr, investing ₹-27 Cr, financing ₹79 Cr, net cash flow ₹23 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | -29 | -13 | 9 | 12 | 7 | 3 |
| Investing Activities | -27 | -4 | -5 | -7 | -5 | -1 |
| Financing Activities | 79 | 23 | -3 | -2 | -1 | -1 |
| Net Cash Flow | 23 | 6 | 1 | 4 | 1 | 1 |